相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
Semanti Mukherjee et al.
CANCER CELL (2022)
Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity
Stefano Angiari et al.
CELL METABOLISM (2020)
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
M. Chalabi et al.
ANNALS OF ONCOLOGY (2020)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
The therapeutic potential of targeting tryptophan catabolism in cancer
Christiane A. Opitz et al.
BRITISH JOURNAL OF CANCER (2020)
Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
Sharanya Sivanand et al.
CANCER CELL (2020)
Amino acids in cancer
Elizabeth L. Lieu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers
Richard W. Joseph et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Nitrogen Metabolism in Cancer and Immunity
Kiran Kurmi et al.
TRENDS IN CELL BIOLOGY (2020)
Pyruvate Kinase M2 Promotes the Activation of Dendritic Cells by Enhancing IL-12p35 Expression
Xin Jin et al.
CELL REPORTS (2020)
Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
Johannes F. Fahrmann et al.
FRONTIERS IN ONCOLOGY (2020)
Cost-Utility Analysis of Pembrolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer With Different PD-L1 Expression Levels
Xiuhua Weng et al.
ONCOLOGY RESEARCH (2020)
Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
Yingjie Bian et al.
NATURE (2020)
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Tingting Wang et al.
NATURE METABOLISM (2020)
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
James S. Lally et al.
CELL METABOLISM (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma
Saeed Daneshmandi et al.
CANCERS (2019)
Control of the Antitumor Immune Response by Cancer Metabolism
Charlotte Domblides et al.
CELLS (2019)
Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity
Michael D. Arensman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Caroline Robert et al.
LANCET ONCOLOGY (2019)
Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function
Will Bailis et al.
NATURE (2019)
Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia
Niki M. Zacharias et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
Zhichen Sun et al.
NATURE COMMUNICATIONS (2019)
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Kathrin Renner et al.
CELL REPORTS (2019)
Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism
Alex J. Bott et al.
CELL REPORTS (2019)
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
Karen G. de la Cruz-Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (> 50%) metastatic squamous and non-squamous non-small cell lung cancer in France
Christos Chouaid et al.
LUNG CANCER (2019)
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
G. Comito et al.
ONCOGENE (2019)
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater
Longjiang She et al.
LUNG CANCER (2019)
Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis
Cathal Harmon et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation
Michihito Kono et al.
JCI INSIGHT (2019)
Reversing lactate-driven immunosuppression using the novel, potent and selective MCT4 inhibitor AZD0095
Susan E. Critchlow et al.
CANCER RESEARCH (2019)
The expanded role of fatty acid metabolism in cancer: new aspects and targets
Ming Chen et al.
PRECISION CLINICAL MEDICINE (2019)
Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence
Ka Shing Cheung et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion
Yukiko Takeuchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways
Michelle van Geldermalsen et al.
BMC CANCER (2018)
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Milica Momcilovic et al.
CANCER CELL (2018)
Downregulation of Membrane Trafficking Proteins and Lactate Conditioning Determine Loss of Dendritic Cell Function in Lung Cancer
Nicoletta Caronni et al.
CANCER RESEARCH (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation
Brenda Raud et al.
CELL METABOLISM (2018)
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Meta-bolic Targets in Cancer Therapy
Xiang Cheng et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Detection and Characterization of CD8+ Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes
Debora Vignali et al.
DIABETES (2018)
Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis
Yajuan Zhang et al.
MOLECULAR CELL (2018)
Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
Roisin M. Loftus et al.
NATURE COMMUNICATIONS (2018)
The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations
Roddy S. O'Connor et al.
SCIENTIFIC REPORTS (2018)
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation
Shankar Revu et al.
CELL REPORTS (2018)
Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions
Ashley V. Menk et al.
CELL REPORTS (2018)
Targeting Tumor Metabolism: A New Challenge to improve immunotherapy
Soumaya Kouidhi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
Thibault Le Bourgeois et al.
FRONTIERS IN ONCOLOGY (2018)
Reinforce the antitumor activity of CD8+ T cells via glutamine restriction
Shogo Nabe et al.
CANCER SCIENCE (2018)
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
Marc O. Johnson et al.
CELL (2018)
Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
Li Jiang et al.
FRONTIERS IN IMMUNOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
A. Cacace et al.
ONCOGENE (2017)
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma
Teresa M. Petrella et al.
EUROPEAN JOURNAL OF CANCER (2017)
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
Omid Hamid et al.
EUROPEAN JOURNAL OF CANCER (2017)
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
Jacob Schachter et al.
LANCET (2017)
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian et al.
LANCET ONCOLOGY (2017)
Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism
Tao Xu et al.
NATURE (2017)
Glucose feeds the TCA cycle via circulating lactate
Sheng Hui et al.
NATURE (2017)
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Arvin M. Gouw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
W. K. Eddie Ip et al.
SCIENCE (2017)
Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Jessica B. Spinelli et al.
SCIENCE (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases
Adonia E. Papathanassiu et al.
NATURE COMMUNICATIONS (2017)
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
Ravyn M. Thompson et al.
ONCOTARGET (2017)
Slc3a2 Mediates Branched-Chain Amino-Acid-Dependent Maintenance of Regulatory T Cells
Kayo Ikeda et al.
CELL REPORTS (2017)
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
J. A. Menendez et al.
ONCOGENESIS (2017)
Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
Eva M. Palsson-McDermott et al.
FRONTIERS IN IMMUNOLOGY (2017)
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Andrew L. Mellor et al.
FRONTIERS IN IMMUNOLOGY (2017)
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Nadine Assmann et al.
NATURE IMMUNOLOGY (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang et al.
CANCER CELL (2017)
Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
Danielle Crawley et al.
BMC CANCER (2017)
M2-like macrophage polarization in high lactic acid-producing head and neck cancer
Toshimitsu Ohashi et al.
CANCER SCIENCE (2017)
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Gabriela Andrejeva et al.
CELL METABOLISM (2017)
Metabolic Instruction of Immunity
Michael D. Buck et al.
CELL (2017)
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase
Yok-Lam Kwong et al.
BLOOD (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
Serine Is an Essential Metabolite for Effector T Cell Expansion
Eric H. Ma et al.
CELL METABOLISM (2017)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Ende Zhao et al.
NATURE IMMUNOLOGY (2016)
Glutaminolysis as a target for cancer therapy
L. Jin et al.
ONCOGENE (2016)
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
Kimberly J. Briggs et al.
CELL (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function
Duojiao Wu et al.
IMMUNITY (2016)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes
Peter J. Siska et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Emerging concepts of T cell metabolism as a target of immunotherapy
Chih-Hao Chang et al.
NATURE IMMUNOLOGY (2016)
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity
Ruth Eichner et al.
NATURE MEDICINE (2016)
Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling
Di Xie et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
PKM2 and cancer: The function of PKM2 beyond glycolysis
Gaochao Dong et al.
ONCOLOGY LETTERS (2016)
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
Abigail S. Krall et al.
NATURE COMMUNICATIONS (2016)
Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis
Ya-Ling Hsu et al.
ONCOTARGET (2016)
Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells
Jiajin Li et al.
ONCOTARGET (2016)
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
Ping-Chih Ho et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Overcoming Hypoxia-Mediated Tumor Progression:Combinatorial Approaches Targeting pH Regulation,Angiogenesis and Immune Dysfunction
Paul C. McDonald et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias
Maria Rosaria Ricciardi et al.
BLOOD (2015)
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Fuming Qiu et al.
CANCER LETTERS (2015)
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Juan R. Cubillos-Ruiz et al.
CELL (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages
Eva M. Palsson-McDermott et al.
CELL METABOLISM (2015)
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Preethi Korangath et al.
CLINICAL CANCER RESEARCH (2015)
Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival
Ulf H. Beier et al.
FASEB JOURNAL (2015)
The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo
Julianna Blagih et al.
IMMUNITY (2015)
The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells
John P. Ray et al.
IMMUNITY (2015)
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
Lian Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
Bi-Yun Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
T cell metabolism drives immunity
Michael D. Buck et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Shingo Eikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity
Buvana Ravishankar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
Targeting AMPK for cancer prevention and treatment
Weidong Li et al.
ONCOTARGET (2015)
Lactate Regulates Metabolic and Proinflammatory Circuits in Control of T Cell Migration and Effector Functions
Robert Haas et al.
PLOS BIOLOGY (2015)
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Valerie A. Gerriets et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
Tiansuo Zhao et al.
ONCOTARGET (2015)
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J. Turley et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
Abhishek K. Jha et al.
IMMUNITY (2015)
AMP-activated protein kinase (AMPK) beyond metabolism A novel genomic stress sensor participating in the DNA damage response pathway
Toran Sanli et al.
CANCER BIOLOGY & THERAPY (2014)
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
George C. Prendergast et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy.
Mario R. Mautino et al.
CANCER RESEARCH (2014)
Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
Joanne R. Doherty et al.
CANCER RESEARCH (2014)
The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
Andrew N. Macintyre et al.
CELL METABOLISM (2014)
Metabolism of activated T lymphocytes
Jason A. Maciolek et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
Mako Nakaya et al.
IMMUNITY (2014)
Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development
David O'Sullivan et al.
IMMUNITY (2014)
Metabolic Reprogramming of Macrophages GLUCOSE TRANSPORTER 1 (GLUT1)-MEDIATED GLUCOSE METABOLISM DRIVES A PROINFLAMMATORY PHENOTYPE
Alex J. Freemerman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cytosolic Branched Chain Aminotransferase (BCATc) Regulates mTORC1 Signaling and Glycolytic Metabolism in CD4+ T Cells
Elitsa A. Ananieva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Regulator of Fatty Acid Metabolism, Acetyl Coenzyme A Carboxylase 1, Controls T Cell Immunity
JangEun Lee et al.
JOURNAL OF IMMUNOLOGY (2014)
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Raymond P. Donnelly et al.
JOURNAL OF IMMUNOLOGY (2014)
Blockade of mTOR Signaling via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-Cell Functions
Yohei Mineharu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
Isabel R. Schlaepfer et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
Xiangyan Li et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
Lifeng Yang et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation
Bart Everts et al.
NATURE IMMUNOLOGY (2014)
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Luciana Berod et al.
NATURE MEDICINE (2014)
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft
Mao-fa Zheng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
Rikke B. Holmgaard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
The SLC16 gene family - Structure, role and regulation in health and disease
Andrew P. Halestrap
MOLECULAR ASPECTS OF MEDICINE (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
Matteo Bellone et al.
ONCOIMMUNOLOGY (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Inhibition of LDH-A by lentivirus-mediated small interfering RNA suppresses intestinal-type gastric cancer tumorigenicity through the downregulation of Oct4
Yongjie Zhang et al.
CANCER LETTERS (2012)
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
Michael Platten et al.
CANCER RESEARCH (2012)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
Gerritje J. W. van der Windt et al.
IMMUNITY (2012)
Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells
Serena Vella et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
Eyal Amiel et al.
JOURNAL OF IMMUNOLOGY (2012)
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation
Sucheta Telang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Metabolic checkpoints in activated T cells
Ruoning Wang et al.
NATURE IMMUNOLOGY (2012)
Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer
Grazia Graziani et al.
PHARMACOLOGICAL RESEARCH (2012)
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response
Marie Beneteau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase
Daniele Covini et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
Regulation and function of mTOR signalling in T cell fate decisions
Hongbo Chi
NATURE REVIEWS IMMUNOLOGY (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
Jing-Jie Tang et al.
CELL METABOLISM (2011)
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
Ruoning Wang et al.
IMMUNITY (2011)
HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
Lewis Z. Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek et al.
JOURNAL OF IMMUNOLOGY (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10
Matthew J. Ovens et al.
BIOCHEMICAL JOURNAL (2010)
Identification of small molecule inhibitors of pyruvate kinase M2
Matthew G. Vander Heiden et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation
Connie M. Krawczyk et al.
BLOOD (2010)
SnapShot: Reactive Oxygen Intermediates (ROI)
Carl Nathan et al.
CELL (2010)
3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
S. Ganapathy-Kanniappan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
The role of mTOR in memory CD8+T-cell differentiation
Koichi Araki et al.
IMMUNOLOGICAL REVIEWS (2010)
pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
Angelo De Milito et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
Juan-Carlos Rodriguez-Prados et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-7 Is Essential for Homeostatic Control of T Cell Metabolism In Vivo
Sarah R. Jacobs et al.
JOURNAL OF IMMUNOLOGY (2010)
Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation
Erikka L. Carr et al.
JOURNAL OF IMMUNOLOGY (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Paul Nicklin et al.
CELL (2009)
Anergic T Cells Are Metabolically Anergic
Yan Zheng et al.
JOURNAL OF IMMUNOLOGY (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
P. Dell'Antone
MEDICINAL CHEMISTRY (2009)
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
Stephen P. Cobbold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Arginine deprivation as a targeted therapy for cancer
L. Feun et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
Candace M. Cham et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1 alpha
Mei Y. Koh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth
Markus Ralser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Energy metabolism in tumor cells
Rafael Moreno-Sanchez et al.
FEBS JOURNAL (2007)
Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?
Ruth Lupu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
Glutamate released by dendritic cells as a novel modulator of T cell activation
Rodrigo Pacheco et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
E Gottfried et al.
BLOOD (2006)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Fuel feeds function: Energy metabolism and the T-cell response
CJ Fox et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death
RL Aft et al.
BRITISH JOURNAL OF CANCER (2002)
CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression
P Kirk et al.
EMBO JOURNAL (2000)
分享论文
